Angiopoietin 2 Market - 2019-2028 - Global Trends, Market Size, Shares, Industry Dynamics, Opportunity Assessment, Competitive Intelligence

Date: Nov 26 2019
|
AllTheResearch (Featured Publisher)
|
Number of Pages: 148
|
Alternate Text Alternate Text Alternate Text Alternate Text

The global angiopoietin 2 market was valued at US$ XX Mn in 2019 and is expected to reach US$ XX Mn by the end of the forecast period, growing at a CAGR of XX% during the period from 2020 to 2028.

The research report segments the market from a relevancy perspective into the below segments and sub-segments with quantitative analysis done from 2018 to 2028 considering 2019 as the base year for the research. Compounded Annual Growth Rate (CAGR) for each respective segment and sub-segment is calculated for the forecast period from 2020 to 2028 to provide a reference for growth potential.

Key Market Players Analysed and Profiled in the Study Include:
Amgen Inc.
AnGes MG, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
MedImmune, LLC
Regeneron Pharmaceuticals, Inc.
RXi Pharmaceuticals Corporation
Silence Therapeutics Plc
Synergys Biotherapeutics, Inc.

Market Segments and Sub-segments Covered in the Report:

Based on Product Type angiopoietin 2 market is segmented into:
Atu-111
BI-836880
LY-3127804
MEDI-3617
Others

Based on Application angiopoietin 2 market is segmented into:
Hospital
Clinic
Others

Based on Geography angiopoietin 2 market is segmented into:
North America (U.S. and Canada)
Europe (U.K., Germany, France, Spain, Italy and Rest of Europe)
Asia Pacific (China, Japan, India, Indonesia and Rest of Asia Pacific)
Latin America (Brazil, Mexico and Rest of Latin America)
Middle East & Africa (GCC, South Africa and Rest of Middle East & Africa)

This report covers an in-depth analysis of the angiopoietin 2 market including statistical and qualitative data points with emphasis on the market dynamics including the drivers, opportunities & restraints.

There is a coverage of market dynamics at country level in the respective regional segments. The report comprises competitive analysis with focus on key players and participants of angiopoietin 2 market covering in-depth data related to competitive landscape, positioning, company profiles, key strategies adopted and product-profiling with focus on market growth and potential.

Key Questions answered in the Report:

• What is the size of the overall angiopoietin 2 market and its segments?
• What are the key segments and sub-segments in the market?
• What are the key drivers, restraints, opportunities and challenges of the angiopoietin 2 market and how they are expected to impact the market?
• What are the attractive investment opportunities within the Market?
• What is the angiopoietin 2 market size at the regional and country level?
• Who are the key market players and their key competitors?
• Market value- chain and key trends impacting every node with reference to companies
• What are the strategies for growth adopted by the key players in angiopoietin 2 market?
• How does a particular company rank against its competitors with respect to revenue, profit comparison, operational efficiency, cost competitiveness and market capitalization?
• How financially strong are the key players in angiopoietin 2 market (revenue and profit margin, market capitalization, expenditure analysis, investment analysis)?
• What are the recent trends in angiopoietin 2 market? (M&A, partnerships, new product developments, expansions)

Years Considered During the Study:

Historical Year: 2018
Base Year: 2019
Forecast Period: 2020 to 2028

Chapter 1 Preface
   1.1 Report Description
          1.1.1 Purpose of the Report
          1.1.2 Target Audience
          1.1.3 USP and Key Offerings
   1.2 Research Scope
   1.3 Research Methodology
          1.3.1 Secondary Research
          1.3.2 Primary Research
          1.3.3 Expert Panel Review
          1.3.4 Approach Adopted
                1.3.4.1 Top-Down Approach
                1.3.4.2 Bottom-Up Approach
          1.3.5 Assumptions
   1.4 Market Segmentation Scope
Chapter 2 Executive Summary
   2.1 Market Summary
          2.1.1 Global Angiopoietin 2 Market, 2018-2026, (US$ Mn)
   2.2 Market Snapshot: Global Angiopoietin 2 Market
          2.2.1 Market Dynamics (DRO)
   2.3 Global Angiopoietin 2 Market, by Segment, 2019
          2.3.1 Global Angiopoietin 2 Market, by Region, 2019 (US$ Mn)
          2.3.2 Global Angiopoietin 2 Market, by Product Type, 2019 (US$ Mn)
          2.3.3 Global Angiopoietin 2 Market, by Application, 2019 (US$ Mn)
   2.4 Premium Insights
          2.4.1 Market In Developed Vs. Developing Economies, 2019 vs 2026
          2.4.2 Market Regional Life Cycle Analysis
          2.4.3 Pricing Analysis, by Region
                2.4.3.1 Pricing by Product
                2.4.3.2 Pricing by Applications
                2.4.3.3 Pricing by Geography/Regions
          2.4.4 Technological Integrations
          2.4.5 Supply Chain Analysis and Vendor Landscaping
          2.4.6 Emerging Player Analysis
          2.4.7 Major Investments in Market
          2.4.8 Mega Trend Analysis
          2.4.9 Regulatory Analysis
          2.4.10 Key Factors Influencing Purchasing/Buying Decisions
          2.4.11 Market Pain-Points and Unmet Needs
Chapter 3 Market Dynamics
   3.1 Market Overview
   3.2 Market Driver, Restraint and Opportunity Analysis
   3.3 Market Ecosystem Analysis
   3.4 Market Trends Analysis
   3.5 Industry Value Chain Analysis
   3.6 Market Analysis
          3.6.1 SWOT Analysis
          3.6.2 Porter's 5 Forces Analysis
   3.7 Analyst Views
Chapter 4 Global Angiopoietin 2 Market, by Product Type
   4.1 Market Overview, by Product Type
          4.1.1 Incremental Opportunity, by Product Type, 2019-2026

Atu-111
BI-836880
LY-3127804
MEDI-3617
Others
Chapter 5 Global Angiopoietin 2 Market, by Application
   5.1 Market Overview, by Application
          5.1.1 Incremental Opportunity, by Application, 2019-2026

Hospital
Clinic
Others
Chapter 6 Global Angiopoietin 2 Market, by Region
   6.1 Market Overview, by Region
          6.1.1 Global Angiopoietin 2 Market, by Region, 2018-2026, (US$ Mn)
   6.2 Incremental Opportunity, by Region, 2019
   6.3 North America Angiopoietin 2 Market
          6.3.1 North America Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
          6.3.2 North America Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
          6.3.3 North America Angiopoietin 2 Market, by Country, 2018-2026 (US$ Mn)
                6.3.3.1 U.S.
                   6.3.3.1.1 U.S. Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.3.3.1.2 U.S. Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
                6.3.3.2 Canada
                   6.3.3.2.1 Canada Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.3.3.2.2 Canada Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
   6.4 Europe Angiopoietin 2 Market
          6.4.1 Europe Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
          6.4.2 Europe Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
          6.4.3 Europe Angiopoietin 2 Market, by Country, 2018-2026 (US$ Mn)
                6.4.3.1 U.K.
                   6.4.3.1.1 U.K. Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.4.3.1.2 U.K. Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
                6.4.3.2 Germany
                   6.4.3.2.1 Germany Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.4.3.2.2 Germany Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
                6.4.3.3 France
                   6.4.3.3.1 France Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.4.3.3.2 France Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
                6.4.3.4 Italy
                   6.4.3.4.1 Italy Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.4.3.4.2 Italy Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
                6.4.3.5 Spain
                   6.4.3.5.1 Spain Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.4.3.5.2 Spain Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
                6.4.3.6 Rest of Europe
                   6.4.3.6.1 Rest of Europe Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.4.3.6.2 Rest of Europe Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
   6.5 Asia Pacific Angiopoietin 2 Market
          6.5.1 Asia Pacific Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
          6.5.2 Asia Pacific Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
          6.5.3 Asia Pacific Angiopoietin 2 Market, by Country, 2018-2026 (US$ Mn)
                6.5.3.1 China
                   6.5.3.1.1 China Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.5.3.1.2 China Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
                6.5.3.2 India
                   6.5.3.2.1 India Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.5.3.2.2 India Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
                6.5.3.3 Japan
                   6.5.3.3.1 Japan Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.5.3.3.2 Japan Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
                6.5.3.4 Indonesia
                   6.5.3.4.1 Indonesia Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.5.3.4.2 Indonesia Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
                6.5.3.5 Rest of Asia Pacific
                   6.5.3.5.1 Rest of Asia Pacific Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.5.3.5.2 Rest of Asia Pacific Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
   6.6 Latin America Angiopoietin 2 Market
          6.6.1 Latin America Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
          6.6.2 Latin America Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
          6.6.3 Latin America Angiopoietin 2 Market, by Country, 2018-2026 (US$ Mn)
                6.6.3.1 Brazil
                   6.6.3.1.1 Brazil Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.6.3.1.2 Brazil Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
                6.6.3.2 Mexico
                   6.6.3.2.1 Mexico Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.6.3.2.2 Mexico Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
                6.6.3.3 Rest of Latin America
                   6.6.3.3.1 Rest of Latin America Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.6.3.3.2 Rest of Latin America Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
   6.7 Middle East & Africa Angiopoietin 2 Market
          6.7.1 Middle East & Africa Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
          6.7.2 Middle East & Africa Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
          6.7.3 Middle East & Africa Angiopoietin 2 Market, by Region/Country, 2018-2026 (US$ Mn)
                6.7.3.1 GCC
                   6.7.3.1.1 GCC Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.7.3.1.2 GCC Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
                6.7.3.2 South Africa
                   6.7.3.2.1 South Africa Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.7.3.2.2 South Africa Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
                6.7.3.3 Rest of Middle East & Africa
                   6.7.3.3.1 Rest of Middle East & Africa Angiopoietin 2 Market, by Product Type, 2018-2026 (US$ Mn)
                   6.7.3.3.2 Rest of Middle East & Africa Angiopoietin 2 Market, by Application, 2018-2026 (US$ Mn)
Chapter 7 Competitive Intelligence
   7.1 Market Players Present in Market Life Cycle
   7.2 Key Player Analysis
   7.3 Market Positioning
   7.4 Market Players Mapping, vis-à-vis Ecosystem
          7.4.1 By Segments
          7.4.2 By Region
   7.5 Strategies Adopted by Key Market Players
   7.6 Recent Developments in the Market
          7.6.1 Organic (New Product Launches, R&D, Financial, Technology)
          7.4.2 Inorganic (Mergers & Acquisitions, Partnership and Alliances, Fund Raise)
Chapter 8 Company Profiles - with focus on Company Fundamentals, Product Portfolio, Financial Analysis, Recent News and Developments, Key Strategic Instances, SWOT Analysis

Amgen Inc.
AnGes MG, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
   F. Hoffmann-La Roche Ltd.

MedImmune, LLC
Regeneron Pharmaceuticals, Inc.
RXi Pharmaceuticals Corporation
Silence Therapeutics Plc
Synergys Biotherapeutics, Inc.
Chapter 9 About Us

Electronic files(PDF) of market research reports will be dispatched within 12 to 24 hours. (Mon-Fri IST)

Select License Type

Need Help?
+
SUBSCRIBE TO THE MAILING TO KEEP UP WITH LATEST NEWS AND UPDATES
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.